Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on developing breakthrough treatments for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
0.9164
0.00 (0.00%)
Range N/A - N/A
Open N/A
Prev Close 0.9164
52 Week 0.80 - 2.00
Volume 0
Market Cap 471.8M
*Delayed 1/23/2015 4:00 EDT

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000